ATLANTA, GA – – (Globe Newswire – May 22, 2023) – – Holzer & Holzer, LLC informs investors that a class action lawsuit has been filed against Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL).  The lawsuit alleges Charles River made materially false and/or misleading statements and/or failed to disclose material adverse facts about the Company’s business, operations, and prospects, including: (1) that Charles River had engaged in illegal activity with respect to its importation of non-human primates for research; (2) that, as a result, Charles River was at a heightened risk of criminal and regulatory investigation by the U.S. Department of Justice; (3) that, as a result, Charles River would be forced to suspend shipments of primates from Cambodia; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you bought shares of Charles River between May 5, 2020 and February 21, 2023, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website www.holzerlaw.com/case/Charles-River/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is July 18, 2023.